News

AlbionVC and Ananda Ventures have led a £3m fundraising round in Raremark, the leading patient-data platform in rare disease. Oltre Venture and, existing major investor, the Cass Entrepreneurship Fund also invested. 

The funding will be used to develop Raremark’s patient-engagement and data-analysis technology, helping biopharmaceutical companies to identify, engage and learn from patients, accelerating the development of new treatments.

Raremark’s platform is the foundation for building research networks of rare disease patients and…

Hazy has been listed by Forbes as one of the Top 15 European Machine Learning companies to watch. Hazy is an AI spin-out from UCL and is one of the businesses invested in by the UCL Technology Fund which is managed by Albion in collaboration with UCLB.

www.forbes.com/15-machine-learning-companies-to-watch-in-europe

Albion is delighted to have been awarded the Investor Allstars 2018  - VCT of The Year Award.

•The judges looked for a track record of fundraising between April 2017 – April 2018 • An impressive level of investment and exits achieved during the period • A reputation for providing valuable strategic and commercial advice to portfolio companies • A strong financial return for private investors

 

Arecor, the UK-based biopharmaceutical formulation company, has raised £6 million from new and existing investors to develop groundbreaking pharmaceutical drugs to transform the treatment of diabetes. The fundraising was led by Calculus Capital, Albion Capital, and Downing Ventures.  BioScience Managers Limited, the international healthcare investment firm, advised Downing Ventures.Through the application of its technology platform, Arecor is creating faster working, more effective drugs that help progress the creation of the next generation of…

Forward Health, the app working to reinvent healthcare communication, has today announced a $3.9M seed funding-round led by Stride.VC , with additional backing from AlbionVC . The funds are joined by an impressive roster of angel backers, including healthtech founders Jay Desai from US company Patient Ping and Melissa Morris from UK-based Lantum .

Forward was founded in 2016 by UK doctors Barney Gilbert and Lydia Yarlott, alongside serial entrepreneur Philip Mundy. Their mission is to connect healthcare systems around the world, making…

UCLTF funded Orchard Therapeutics, a biotechnology company dedicated to transforming the lives of patients with rare disorders through innovative gene therapies, today announced the completion of an oversubscribed $150 million Series C financing.is one of the early

Deerfield Management led the financing with significant new investments from RA Capital Management, Venrock, Foresite Capital, Perceptive Advisors, Cormorant Asset Management LP, ArrowMark Partners, Sphera Global Healthcare, Medison Ventures, Driehaus Capital Management and Ghost…

UCLH Cancer Collaborative has today launched the first pilot project of an NHS ovarian cancer surveillance service for women who carry a faulty BRCA gene and have chosen not to have their ovaries and fallopian tubes removed.

The pilot, known as the ALDO project (Avoiding Late Diagnosis in Ovarian Cancer), aims to recruit 2,000 women aged over 35 from across England [1] and will use Abcodia’s ROCA© Test as part of an NHS service to detect ovarian cancer amongst BRCA-carriers before they have any symptoms. The ROCA Test uses an algorithm to…

Funding led by the UCL Technology Fund with participation from: Nationwide Building Society, Pentland, Amadeus Capital Partners and AI Seed

Hazy, the London-based AI company enabling ethical, effortless and GDPR-compliant data sharing for responsible businesses, has announced an additional $1.8 million seed funding led by UCL Technology Fund, alongside Nationwide Building Society, Pentland, Amadeus Capital Partners, AI Seed and other investors.

This takes Hazy’s total seed funding to $2.8 million following a $1 million investment from…